“The promotion of lung cancer screening to the U.S. Hispanic population has been a disaster”

We have data since 2011 that there is a 20 precent reduced lung cancer mortality with low-dose CT lung cancer screening, says Luis E. Raez, MD, of Memorial Cancer Institute/Florida International University in Miami.

It took Medicare and payers more than 5 years to agree that the benefit is worth it and they started to cover it, he points out. “Now, only 4% of the patients that can benefit are screened nationwide because we are not doing enough to promote it in all races or ethnic groups.”

See “Luis E. Raez, MD, on Boosting Lung Cancer Outcomes in Hispanics” by Shalmali Pal on the MedPage Today website (September 18, 2020)